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Summary
Objective: To identify the gene expression proﬁle of mandibular condylar cartilage after experimentally induced osteoarthritis (OA).
Design: We studied the gene expression levels in temporomandibular joint (TMJ) condylar cartilage during different stages of experimentally
induced OA. The pathological characteristics of normal, early-stage and late-stage osteoarthritic TMJ cartilage were veriﬁed by histological
techniques. The gene expression proﬁles in normal and osteoarthritic cartilage were measured by Affymetrix RAE230A microarrays. Some of
the gene transcripts were conﬁrmed by quantitative real-time reverse-transcription PCR analysis.
Results: A comprehensive, differentially expressed, gene proﬁle was obtained in TMJ cartilage during the progression of OA. In total, 138
genes and expressed sequence tags were up- or down-regulated at least 2-fold. Some of these genes have been shown to play a role in OA,
including matrix-degrading proteases, protease inhibitors and genes involved in cell growth, apoptosis and bone remodeling. However, some
genes that had never been reported to be related with OA, such as AQP3, SPP2, NOV, DKK3 and EGLN3, were consistently observed to be
up-regulated in this study, suggesting they may be involved in OA progression.
Conclusion: This study provides a new gene expression proﬁle of the progression of OA. Further study of these OA-related genes may provide
new insights into understanding the molecular mechanisms underlying OA.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) results from an imbalance between
chondrocyte-controlled anabolic and catabolic processes,
and is characterized by progressive degradation of compo-
nents of the extracellular matrix (ECM) within the articular
cartilage, associated with secondary inﬂammatory factors1.
The temporomandibular joint (TMJ) plays an important role
in craniofacial growth and function, and shows a high
incidence of OA2. TMJ is one of many synovial joints and
data gathered from other synovial joints about OA can
sometimes be applied to the TMJ3. However, each joint has
its unique function, e.g., the knee joint is a load-bearing joint
whereas TMJ is a shear-bearing joint4. OA lesions tend to
develop mainly in old age in the knee joint5,6, whereas OA
lesions in the TMJ can be seen in relatively young patients
and animals2,7,8.
Articular cartilage is composed of ECM and chondro-
cytes. Chondrocytes, predominant in the cartilage of the
TMJ, control the synthesis and degradation of articular ECM
components3. Many studies had investigated the morpho-
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Received 20 November 2004; revision accepted 27 March 2005.111logical and biochemical changes that occur during disease
progression. Although several genes related to OA had
been found, a comprehensive study of the gene expression
proﬁles of osteoarthritic cartilage in the TMJ is still missing.
Microarray analysis is a powerful technique to study
gene expression. This technique enables researchers to
detect the relative concentration of thousands of transcripts
in a single experiment and has become the most common
approach for the study of gene functions, drug evaluation,
pathway dissection and classiﬁcation of clinical samp-
les9e11. Recently, researchers have used this technology
to study gene expression during OA. Aigner et al. studied
the anabolic and catabolic gene expression patterns in
normal vs osteoarthritic cartilage using a cDNA array12.
Moreover, clusterin and beta-2 microglobulin were identiﬁed
to be involved in OA pathogenesis using microarray
analysis13,14. This technology has also been applied to
study the gene expression patterns of chondrocytes, in
vitro15,16. Spears et al. recently studied tumor necrosis
factor (TNF) expression in adjuvant-induced arthritis in the
TMJ with the use of a cDNA microarray containing 1148
genes. Samples from TMJ tissue (synovium, retrodiscal
tissue and articular disc) were pooled to study the
expression of TNF-alpha and its receptors in acute in-
ﬂammation17. All these studies have shed light on the
molecular mechanisms underlying OA and demonstrated
the biological complexity of this disease. However, the5
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progress made, in that they: (1) include ﬁnite numbers of
representative gene probe sets on commercial microarrays,
(2) are unable to detect splice variants, and (3) have
a shortage of suitable data mining tools.
Our studyhas focusedon identifying somenovel candidate
genes relating to OA. A comprehensivemolecular proﬁling of
OA progression is an important ﬁrst step in discovering new
candidate targetmolecules that are potentially involved in the
pathogenesis of OA. In present study, Affymetrix RAE230A
microarrays were used to simultaneously compare the
expression of over 15,000 transcripts between rats with
osteoarthritic cartilage of the TMJ and normal controls. We
identiﬁed many novel genes that were differentially ex-
pressed in osteoarthritic cartilage. Some of these gene
transcripts were further analyzed by quantitative real-time
reverse transcriptase polymerase chain reaction (RT-PCR)
to validate data gathered from the DNA microarray analysis.
To the best of our knowledge, this study represents the ﬁrst
report of gene expression patterns in osteoarthritic cartilage
in the TMJ using DNA microarray analysis.
Materials and methods
SURGICAL PROCEDURES
The study was performed in accordance with Peking
University Animal Care Regulations. Two-month-old male
Wistar rats (200e220 g) were anesthetized with sodium
pentobarbital (50 mg/kg). To induce OA, lesions were
created in the discs of the TMJ as described by Lekkas
et al.18, with minor modiﬁcations. Under sterile surgical
conditions, the left TMJ was exposed and one-third of the
disc in the anterior and lateral regions of the joint was
resected. The incision was then sutured and rats were
given a normal diet for the remainder of the experiment.
Age-matched rats with no surgical operation on both sides
of TMJ were used as normal controls.
PATHOLOGICAL EXAMINATION
Rats were killed at 2, 4, 6, 8, or 12 weeks postoperatively
with an overdose of sodium pentobarbital (O70 mg/kg). The
left condyles of the TMJs were removed and ﬁxed in 4%
paraformaldehyde in phosphate buffered salt solution
(PBS) and demineralized in 15% EDTA. The specimens
were dehydrated in graded alcohols and xylene, embedded
in parafﬁn, and cut serially into 5-mm sagittal sections. The
sections were stained with hematoxylineeosin and toluidine
blue. The pathological conditions of OA were determined
according to the histological criteria described by Dijkgraaf
et al.1.
TISSUE AND RNA PREPARATION
Two time points, 4 and 12 weeks postoperatively, were
selected for studying the differential gene expression
pattern of normal and osteoarthritic TMJ cartilage using
DNA microarrays. Mandibular condyles were removed and
condylar cartilage was carefully separated from the un-
derlying bone, rapidly submerged in RNAlater (Qiagen) and
stored at 20(C until RNA extraction. Total RNA was
extracted using Trizol Reagent (Invitrogen Life Technolo-
gies) according to the manufacturer’s instruction, after the
cartilage samples were homogenized in liquid nitrogen
with a pestle and a mortar. The RNA sample was furtherpuriﬁed with RNeasy Mini Column (Qiagen). The RNA
concentration was evaluated by A260/A280 measurement
and quality assessed by electrophoresis on a 1.0% agarose
gel. Each RNA sample used for hybridization was extracted
from 10 mandibular condyles to ensure adequate amount of
tissue for RNA analysis and to decrease animal-to-animal
variance. At per time point, we used three separate OA
samples (30 rats), and three separate normal control
samples (30 rats) for hybridization.
PROBE PREPARATION
Microarray hybridization probes, derived from isolated
RNA samples, were generated in the following steps:
reverse transcription of 10 mg of total RNA was performed
using an oligo (dT) primer containing T7 promoter (Operon)
and SuperScript II reverse transcriptase (Invitrogen Life
Technologies) in a reaction volume of 20 mL to obtain ﬁrst
strand cDNAs. Second strand cDNAs were then synthe-
sized in a total volume of 150 mL. The double-stranded
cDNA was puriﬁed using phenol chloroform and biotin-
labeled cRNA was synthesized using Enzo RNA Transcript
Labeling Kit (Affymetrix). In vitro transcription products were
puriﬁed using RNeasy Columns, and biotinylated cRNA
probes were fragmented.
HYBRIDIZATION
Biotinylated fragmented cRNA probes were hybridized in
the microarray RAE230A (Affymetrix, Santa Clara, CA),
which contained probe sets of over 15,000 known tran-
scripts and expressed sequence tags (ESTs). Hybridization
was performed at 45(C for 16 h in a hybridization oven
(Affymetrix). The microarrays were then automatically
washed and stained with streptavidinephycoerythrin con-
jugate in an Affymetrix Genechip Fluidics Station. Fluores-
cence intensities were scanned with a GeneArray Scanner
(Affymetrix). Hybridization was carried out independently, in
triplicate, at each time point.
MICROARRAY DATA ANALYSIS
An Affymetrix Genechip Operating System 1.2 (GCOS1.2)
was used to analyze the scanned image and to obtain and
scale quantitative information (according to the Affymetrix
Statistical Algorithms Reference Guide). Student’s t tests
(unpaired, two-tailed, unequal variance) were used to
analyze and determine the signiﬁcance of changes in the
means of the following groups: control vs early-stage OA,
control vs late-stage OA, and early-stage OA vs late-stage
OA. The transcripts with P-values !0.05 were selected for
further analysis. A scaling signal intensity was generated for
each probe using GCOS1.2 and triplicate scaling signal
intensities from three independent experiments were then
averaged to generate the average signal intensity (ASI) for
each probe. Changes in intensity were then calculated.
In brief, differentially expressed genes in normal and
different stages of OA were ﬁltered according to the
following criteria e (1) ﬁlter on t test: an unpaired t test
was used to assess statistical signiﬁcance, with a signiﬁ-
cance level of P! 0.05; (2) ﬁlter on signal: present in at
least two of six samples in each comparison; (3) genes that
were R2-fold up- or down-regulated between any two
groups were selected.
The selected genes were uploaded to Netaffx (http://
www.affymetrix.com) for analysis and were annotated
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characterizes genes based on deﬁned categories of molec-
ular function, biological process, and cellular component.
CLUSTER ANALYSIS
A self-organizing map (SOM) was performed for the
analysis and visualization of gene expression proﬁles
based on differentially expressed genes using Affymetrix
Data Mining Tool 3.0. Genes were then annotated using
GO classiﬁcations.
QUANTITATIVE REAL-TIME RT-PCR ANALYSIS
Five differentially expressed genes were selected from the
microarray results to further conﬁrm the reliability of the array
data. Total RNA was isolated using Trizol Reagent (Invi-
trogen Life Technologies) according to the manufacturer’s
protocol after cartilage samples were homogenized with
a pestle and a mortar in liquid nitrogen. One microgram total
RNA of normal or osteoarthritic cartilage was reverse
transcribed to cDNA. Single-strand cDNA was synthesized
with SuperScript II reverse transcriptase (Invitrogen Life
Technologies). Quantitative real-time PCR was performed in
Rotor-Gene 3000 (Corbett Research) with a Uniprimer in
PCR by using S7901 Amplifuor Universal Ampliﬁcation
and Detection System (Chemicon) according to the manu-
facturer’s instructions and the principle was described by
Nuovo et al.20. PCR was performed by mixing 2.5 mL of 10!
PCR buffer with 15 mM MgCl2, 2.5 mL of 2.5 mM dNTP,
2.5 mL of 10! Z-tailed primer (0.5 mM), 2.5 mL of 10!
untailed primer (5 mM), 2.5 mL of Ampliﬂuor UniPrimer,
0.25 mL of Taq polymerase (5 units/ml), 10.25 mL ddH2O and
2.0 mLDNA sample in 25 mL reactions. Each experiment was
done in triplicate. The expression levels of mRNA were
normalized by the average expression of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). The primer sets for
the six genes were designed as presented in Table I.
STATISTICAL ANALYSIS
Data are presented as meanG standard error (S.E.),
and comparisons between groups were performed usingStudent’s unpaired t test and considered to be signiﬁcant if
P! 0.05.
Results
PATHOLOGICAL EXAMINATION
Histological examination of mandibular condylar cartilage
(MCC) in the postoperative rat demonstrated time-related
progressive osteoarthritic changes. Normal cartilage had
a smooth, intact superﬁcial zone and no loss of proteoglycan
staining in the mid- or deep zones, as determined by
toluidine blue. In contrast, cartilage at 4 weeks postopera-
tively showed early-stage osteoarthritic changes, including
swelling, superﬁcial ﬁbrillation and uneven proteoglycan
staining. Cartilage at 6 and 8 weeks postoperatively
demonstrated intermediate-stage osteoarthritic changes,
including horizontal splitting, cluster formation and loss of
proteoglycan staining. Cartilage at 12 weeks showed late-
stage osteoarthritic changes, including extensive ﬁbrillation,
severely structural disorganization and extensive loss of
proteoglycan staining (Fig. 1). Cartilage at two time points, 4
and 12 weeks postoperatively were selected to study the
gene expression patterns during the progression of OA.
MICROARRAY DATA AND CLUSTER ANALYSIS
We compared gene expression proﬁles between normal
and osteoarthritic TMJ cartilage using the Affymetrix
oligonucleotide microarray technique. Among the 15,000
tested transcripts and ESTs, 1279 showed a statistical
difference in expression. Of these 1279, 138 showed over
a 2-fold change during the progression of OA. The
information for each probe set on the RAE230A microarray
was acquired in Netaffx (http://www.affymetrix.com, down-
loaded on January 12, 2005). Classiﬁcation of the 138
strongly differentially expressed genes was performed
according to the annotations of GO (http://www.geneonto-
logy.org, downloaded on January 12, 2005). Among the 138
genes, 76 have been sequenced at full-length and the
others were ESTs. The genes with known sequences were
classiﬁed according to GO, in terms of molecular function
and biological process, and sorted by percentages accord-
ing to FatiGO (http://fatigo.bioinfo.cnio.es), a web interfaceTable I
Primer sets used for the quantitative real-time RT-PCR analysis*
Gene
symbol
Primers (5#e3#) Product size
(bp)
Annealing
temperature
((C)
GAPDH Forward act gaa cct gac cgt aca CAT GGC CTT CCG TGT TCC T 107 55.0
Reverse CGC CTG CTT CAC CAC CTT CT
NOV Forward CGC CCT TCA ATA CCA AAA CCA 184 53.0
Reverse act gaa cct gac cgt aca TTC CCT GGG CAC CTG TTA CAT
EGLN3 Forward act gaa cct gac cgt aca CCC CAT GGC TCT GTT TTG TTT 121 53.0
Reverse TCC CTG CCT TCG TTG TGT TTA
MMP3 Forward TGG AAG GCG TCG TGT GTT T 108 54.0
Reverse act gaa cct gac cgt aca CTC CCA TTT TGC TCT GCC ATA
AQP3 Forward ACC CAG GAG TGC GTT TCT AAG TA 174 54.0
Reverse act gaa cct gac cgt aca GCC CCT CCC AAT GTC TAT CTT
DKK3 Forward CAG GGA GGG TAT GGC GTT AGA 102 53.0
Reverse act gaa cct gac cgt aca AAG GGA AAG AGG GAG AAA GCT
*One primer is designed to contain target-speciﬁc sequences plus the Z sequence at the 50 end (Z-tailed primer), and the other primer
contains only target-speciﬁc sequences (untailed primer). Z sequence: act gaa cct gac cgt aca. The UniPrimer consists of a 30
oligonucleotide tail (Z sequence) and 50 intra-complementary sequence labeled with a pair of energy transfer molecules.
1118 J. Meng et al.: Differential gene expression in TMJFig. 1. Pathological examinations of MCCs postoperatively and normal controls. A, B: A smooth, intact superﬁcial zone and no loss of
proteoglycan staining in the mid- or deep zones are visible in normal adult cartilage. C, D: Cartilage at 4 weeks postoperatively showed
swelling, superﬁcial ﬁbrillation and uneven proteoglycan staining. E, F: Cartilage at 12 weeks postoperatively showed extensive ﬁbrillation,
severely structural disorganization and extensive loss of proteoglycan staining throughout the mid- and deep zone. (A, C, E:
hematoxylineeosin staining ! 100; B, D, F: toluidine blue staining ! 100).which carries out data mining using GO for DNA microarray
data21 (Figs. 2 and 3).
SOM is an unsupervised, neural network learning
algorithm which has been successfully used for the analysis
and organization of large data ﬁles22. This clustering
algorithm allows for the separation of distinct patterns of
expression based on the similarity of expression proﬁles
between different genes. SOM clustering analysis of the
138 altered genes revealed four unique patterns of gene
expression (Fig. 4), and these genes were grouped into four
clusters (clusters 1e4). Gene expression ratios of 138 tran-
scripts in different clusters are shown in Tables IIeV.QUANTITATIVE REAL-TIME RT-PCR ANALYSIS
To further validate the results of the microarray analysis,
ﬁve genes having over 2-fold changes in microarray
analysis were selected for conﬁrmation by using quantita-
tive real-time RT-PCR analysis. The expression levels of
mRNA were normalized by the average expression of
GAPDH and the results are shown in Fig. 5. The mRNA
expression of MMP3, AQP3, NOV, DKK3, and EGLN3 were
analyzed by quantitative PCR and revealed a similar
expression pattern to microarray results, demonstrating
a good correlation between the two methods.
1119Osteoarthritis and Cartilage Vol. 13, No. 12Fig. 2. Classiﬁcation of molecular functions. The differentially expressed genes with a R2-fold change in the progression of OA were
classiﬁed according to molecular functions of GO annotations. FatiGO extract GO terms annotated for these genes sorting by percentages
(levelZ 3). Percentages are calculated with respect to only those genes that have been GO annotated.Discussion
The current study was performed directly on MCC, which
can better represent the osteoarthritic state in vivo than
isolated chondrocyte, synovial ﬂuid, or cultured explants.
Because of scarce availability of human TMJ cartilage,
especially in the early-stage of the disease, an animal
model has been created to study changes of TMJ cartilage
in different stages of OA and to assess new therapeutic
strategies. In the present study, we induced experimental
OA in the TMJ based on surgical procedures described byLekkas23 and conﬁrmed OA by pathological examination.
While there are some drawbacks to using a DNA micro-
array, e.g., missing post-transcriptional regulation and post-
translational modiﬁcations or incomplete relevance of
mRNA level vs protein level, the technique provides
a powerful tool for obtaining an overview of gene
expression patterns, which is something hardly achievable
with other techniques24. Real-time RT-PCR was performed
to conﬁrm the results of microarray analysis and revealed
a good correlation between these two methods.Fig. 3. Classiﬁcation of biological processes. The differentially expressed genes with a R2-fold change in the progression of OA were
classiﬁed according to the biological processes of GO annotations. FatiGO extract GO terms annotated for these genes sorting by
percentages (levelZ 3). Percentages are calculated with respect to only those genes that have been GO annotated.
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expression proﬁles between normal and osteoarthritic TMJ
cartilage in rats. According to GO annotations, these genes
spanned many members of distinct functional families,
including ion binding, protein binding, nucleic acid binding,
receptor activity, hydrolase activity, enzyme inhibitor activ-
ity, transcription factor activity, oxidoreductase activity and
structural molecule activity. These genes also encom-
passed many biological processes, including metabolism,
morphogenesis, cell growth and death, cell communication,
regulation of development and cell differentiation.
SOM analysis of the 138 genes revealed four unique
patterns, or clusters, of gene expression (Fig. 4). Cluster 1
included 81 transcripts which had continuous elevation from
early to late-stage OA, suggesting that these genes may
play roles during the entire progression of OA. Cluster 1
included many known genes, such as MMP3, SPIN2C,
PLAT, CHAD, TNFRSF11B, CLU, SFRP4 and HIG1 which
have been shown to be associated with OA13,14,25. In
addition, some new genes and ESTs which haven’t been
previously been associated with OA, were also included in
this cluster. Cluster 2 contained 7 transcripts which showed
little or no down-regulation in early-stage OA and then
a dramatic up-regulation in late-stage OA. This cluster
mainly consisted of ESTs. However, member 11 of the
tumor necrosis factor ligand superfamily member (TNFSF
11), an osteoclast differentiation factor which induces
osteoclast formation and bone resoprtion26, appeared to
be up-regulated in late-stage OA. Thus, it may be involved
in bone resorption in late-stage OA. Cluster 3 included 16
transcripts, which rapidly increased and almost peaked at
the early-stage time point, which suggests that these genes
may play roles in the initiation of OA, and may thus be used
as markers of early-stage OA. The high expression of
TIMP3 and GSR within this cluster suggests a protective
Fig. 4. SOM clustering analysis. One hundred and thirty-eight
differentially expressed genes were grouped into four clusters
according to SOM clustering algorithm. X- and Y-axes represent
time point and relative expression levels, respectively. From left to
right, the ﬁrst point shows normal control values, the second point
shows early-stage OA expression levels, and the ﬁnal point shows
late-stage OA expression levels. Each of the four clusters
demonstrated a unique pattern of expression based on the
similarity of the expression pattern of its constituent genes. The
number of transcripts in each cluster is shown in parenthesis.effect in early-stage of OA. However, the molecular
functions of most of the transcripts in this cluster are still
not clear according to GO classiﬁcation and their relations
to OA need to be further studied. Cluster 4 included
transcripts which were continuously down-regulated during
OA progression. The most striking inhibition was observed
in chondromodulin-1 (CHM-1), a cartilage derived anti-
angiogenic factor, which has been shown to regulate
vascular invasion during endochondral bone formation.
CHM-1, which is highly expressed in articular cartilage,
plays a role in the maintenance of avascularity of normal
cartilage. Thus, decreased levels of CHM-1 might be
partially responsible for promoting blood vessel invasion
into the cartilage during OA27,28. Bone morphogenetic
proteins (BMPs) induce cartilage and bone formation29,
and the down-regulation of BMP1 and BMP3 may be
related to the disorders of cartilage and bone formation
during OA.
After integrating information from GO classiﬁcations and
SOM clustering analysis, there appears to be a series of
very complicated molecular events that contribute to OA
progression. Each unique SOM pattern included transcripts
from different classiﬁcations. In cluster 1, the up-regulated
genes not only included genes related to proteolysis like
MMP3, PLAT and C1S, but also some apoptosis-related
genes, like TNFRSF11B, EGLN3 and CLU. Moreover,
increased IGFBP5 and IGFBP6 expressions in cluster 1
may block IGF-I activity and potentially inhibit the anabolic
activities of chondrocytes30. Down-regulation of BMP1 and
BMP3 in cluster 4 and imbalance of TNFSF11 (cluster 2)
and TNFRSF11B (cluster 1) may cooperate in the damage
of bone and cartilage during OA. Interestingly, though,
genes in the same classiﬁcation sometime had different
expression levels. For example, the enzyme inhibiting
activity of SERPINA1, SPIN2C and SPP2 (cluster 1)
continuously increased, but A2M, a wide-spectrum pro-
tease inhibitor signiﬁcantly decreased (cluster 4), and
TIMP3 increased and peaked in early-stage (cluster 3).
The mechanisms governing these changes are not clear,
but considering the high expression of proteinases in cluster
1, it’s possible that a balance between the proteinase and
its inhibitor was disturbed. This balance may play an
important role in the pathogenesis of OA.
In the present study, a widespread differential gene
expression proﬁle was made in OA progression, as
mentioned above. Many of these genes have been
previously demonstrated to be associated with OA, and
more importantly, we have uncovered numerous new genes
and ESTs which have never been related to OA. However,
it should be noted that only transcripts R 2-fold change in
expression were selected, some important genes that are
expressed or repressed during OA progression might have
been missed in this study. Although our main focus was on
cluster 1, the biggest of the four clusters, and the validation
of genes was performed mainly from this cluster, the other
clusters may be equally important during OA progression.
Additionally, some ESTs may play potential roles in OA.
Thus, further studies are needed.
Aquaporins (AQPs) are integral membrane proteins that
serve as channels for water transport across the mem-
brane. A recent report showed that AQP1 was expressed in
articular chondrocytes and up-regulated in rheumatoid
arthritis (RA)31. Additionally, AQP3 was expressed in
normal equine articular chondrocytes32. Although AQP1e9
genes are present on the microarray of RAT230A, only
AQP1, AQP3 and AQP6 were expressed in MCC in the
present study. AQP3 mRNA was highly up-regulated in OA
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Gene expression ratios of 81 transcripts in cluster 1
Genebank identiﬁer Gene title Gene
symbol
EOA vs CO LOA vs CO
BI291181 Secreted phosphoprotein 2, 24 kDa Spp2 19.0 32.0
NM_012880 Superoxide dismutase 3 Sod3 3.7 9.6
BI290821 EST e 3.0 7.4
NM_022519 Serine (or cysteine) proteinase inhibitor, clade A, member 1 Serpina1 2.0 6.9
AI599143 EST e 3.2 6.8
AF140346 Secreted frizzled-related protein 4 Sfrp4 2.0 6.2
BG373119 EST e 2.2 6.0
NM_031531 Serine protease inhibitor Spin2c 3.6 5.9
NM_017149 Mesenchyme homeobox 2 Meox2 2.6 5.2
BG673439 Claudin 11 Cldn11 2.6 5.1
D88250 Complement component 1, s subcomponent Cls 2.6 4.9
NM_012870 Tumor necrosis factor receptor superfamily, member 11b
(osteoprotegerin)
Tnfrsf11b 2.9 4.9
NM_013104 Insulin-like growth factor-binding protein 6 Igfbp6 2.3 4.8
BM388957 EST e 3.1 4.7
NM_031609 Neuroblastoma, suppression of tumorigenicity 1 Nb11 2.0 4.6
X89963 Thrombospondin 4 Thbs4 2.7 4.6
AF109674 Late gestation lung protein 1 Lg11 1.6 4.6
NM_019164 Chondroadherin Chad 2.8 4.5
M25804 Nuclear receptor subfamily 1, group D, member 1 Nr1d1 2.2 4.5
AI011747 Proline arginine-rich end leucine-rich repeat protein Prelp 2.7 4.5
BG673588 Insulin-like growth factor binding protein 6 Igfbp6 2.1 4.4
NM_016996 Calcium-sensing receptor Casr 1.6 4.3
AF314657 Clusterin Clu 1.8 4.2
AI411941 EST e 2.4 4.2
AI175861 Late gestation lung protein 1 Lg11 1.4 4.0
U23407 Cellular retinoic acid binding protein 2 Crabp2 2.0 3.9
NM_133523 Matrix metalloproteinase-3 Mmp3 2.5 3.6
NM_031556 Caveolin Cav 2.1 3.6
NM_022270 Organic cation transporter OCTN1 Octnl 2.4 3.5
AI716243 EST e 2.3 3.3
NM_017254 5-Hydroxytryptamine (serotonin) receptor 2A Htr2a 2.0 3.2
BF418649 EST e 1.6 3.2
AI410438 EST e 1.3 3.1
AB071036 Leucine-rich repeat protein induced by beta-amyloid Lib 1.9 3.1
NM_021576 5 Nucleotidase Nt5 1.8 3.0
BI281230 EST e 1.7 3.0
AF347936 Interleukin 11 receptor, alpha chain 1 Il11ra1 1.4 3.0
BE104060 Insulin-like growth factor-binding protein 5 Igfbp5 1.4 2.9
NM_031703 Aquaporin 3 Aqp3 1.8 2.9
BI285449 Caveolin Cav 1.9 2.9
BI278545 Dermatopontin Dpt 2.0 2.8
BI285485 Dermatopontin Dpt 1.9 2.8
BG379319 Transforming growth factor, beta induced, 68 kDa Tgfbi 2.2 2.7
NM_012636 Parathyroid hormone-like peptide Pthlh 2.1 2.7
BI292028 Guanine deaminase Gda 2.1 2.7
BM390827 EST e 1.7 2.7
NM_0 19371 EGL nine homolog 3 (C. elegans) Egln3 2.0 2.7
AF245040 Dickkopf homolog 3 (Xenopus laevis) Dkk3 1.6 2.7
BM387419 EST e 1.5 2.6
AI406412 EST e 1.4 2.6
BI285086 EST e 1.6 2.6
NM_133569 Angiopoietin-like 2 Angpt12 2.0 2.5
AA819776 Heat shock protein 1, alpha Hspca 1.6 2.5
BF551311 EST e 1.7 2.5
AA965084 EST e 1.7 2.5
U44948 Cysteine and glycine-rich protein 2 Csrp2 1.9 2.5
AF245172 Guanine deaminase Gda 2.0 2.5
AIO10883 EST e 1.4 2.4
NM_030868 NOV protein Nov 1.6 2.4
NM_033499 Scrapie responsive gene 1 Scrg1 1.7 2.4
AI600037 EST e 1.8 2.4
BE113700 Paired related homeobox 2 Prrx2 1.2 2.4
NM_080698 Fibromodulin Fmod 1.9 2.4
BI296216 EST e 1.4 2.4
BG671569 EST e 1.4 2.4
AI233530 EST e 1.3 2.4
(continued on next page)
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Genebank identiﬁer Gene title Gene
symbol
EOA vs CO LOA vs CO
NM_013151 Plasminogen activator, tissue Plat 1.2 2.3
H31665 Hypoxia induced gene 1 Hig1 1.4 2.3
J04035 Elastin Eln 1.7 2.2
AA963797 EST e 1.5 2.2
BM389225 Angiopoietin-like 2 Angpt12 1.8 2.2
BM384570 EST e 1.5 2.2
AA892549 EST e 1.4 2.1
BM389611 EST e 1.4 2.1
AA892234 EST e 1.4 2.1
AA875017 EST e 1.2 2.1
BI276341 EST e 1.2 2.1
BI292351 EST e 1.4 2.1
NM_022290 Tenomodulin Tnmd 1.7 2.1
Al102401 EST e 1.4 2.1
AB073318 Brain and acute leukemia, cytoplasmic Baalc 1.2 2.0
EOA vs CO: early-stage OA vs control; LOA vs CO: late-stage OA vs control. List sorted according to the fold change of LOA vs CO in
descending order.
Table III
Gene expression ratios of seven transcripts in cluster 2
Genebank identiﬁer Gene title Gene
symbol
EOA vs CO LOA vs CO
NM_022242 Niban protein Niban 1.0 2.5
AA963085 EST e 0.9 2.3
BF406261 Similar to fatty acid transport protein 3 e 1.0 2.2
NM_057149 Tumor necrosis factor (ligand)
superfamily, member 11
Tnfsf11 1.1 2.0
BI275179 EST e 0.8 2.0
BF400611 EST e 0.8 2.0
BI287026 EST e 0.7 2.0
EOA vs CO: early-stage OA vs control; LOA vs CO: late-stage OA vs control. List sorted according to the fold change of LOA vs CO in
descending order.
Table IV
Gene expression ratios of 16 transcripts in cluster 3
Genebank identiﬁer Gene title Gene symbol EOA vs CO LOA vs CO
BM383043 Similar to hypothetical protein 4933417N17 e 4.8 4.1
925924 Similar to cytokine receptor like molecule 3 LOC290655 3.7 3.3
AI717113 Coagulation factor 5 F5 3.3 3.2
BI298356 Four and a half LIM domains 1 Fh11 2.8 2.9
BG673187 Four and a half LIM domains 1 Fh11 2.6 2.2
BG380282 Crystallin, alpha c Cryac 2.4 2.4
AW520914 Calsequestrin 2 Casq2 2.3 2.5
AI599265 Tissue inhibitor of metalloproteinase-3 Timp3 2.3 2.1
NM_053906 Glutathione reductase Gsr 2.2 1.6
BI285456 Granulosa cell HMG-box protein 1 Gcx-1 2.1 2.6
AI237401 EST e 2.1 2.0
AI406795 EST e 2.1 2.5
AI549393 EST e 2.1 2.1
BI289517 EST e 2.0 1.8
AI235906 Similar to protein phosphatase 2C epsilon LOC3 10506 2.0 2.1
BI300986 EST e 1.9 2.3
EOA vs CO: early-stage OA vs control; LOA vs CO: late-stage OA vs control. List sorted according to the fold change of EOA vs CO in
descending order.
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Gene expression ratios of 34 transcripts in cluster 4
Genebank identiﬁer Gene title Gene symbol EOA vs CO LOA vs CO
NM_030854 Chondromodulin-1 Chm-1 0.2 0.1
BF284168 H19 fetal liver mRNA H19 1.0 0.2
AI408151 EST e 0.4 0.2
NM_012488 Alpha-2-macroglobulin A2m 0.5 0.3
NM_019348 Somatostatin receptor 2 Sstr2 1.0 0.3
NM_012760 Pleiomorphic adenoma gene-like 1 Plag11 0.4 0.3
AI102732 EST e 0.8 0.3
AI639162 EST e 0.8 0.4
AA891634 EST e 0.4 0.4
NM_017105 Bone morphogenetic protein 3 Bmp3 0.6 0.4
BF289017 EST e 0.8 0.4
BF285466 EST e 0.5 0.4
AI009713 EST e 0.6 0.4
AB012139 Bone morphogenetic protein 1 Bmp1 0.6 0.5
BI285551 Similar to hypothetical protein FLJ12442 e 0.7 0.5
AA892497 Xylosyltransferase II Xy1t2 1.0 0.5
NM_017058 Vitamin D receptor Vdr 0.7 0.5
NM_031333 Cadherin 2 Cdh2 0.6 0.5
U73184 Syndecan 3 Sdc3 0.6 0.5
AI071102 EST e 0.5 0.5
BI279363 EST e 0.6 0.5
AI230228 Phosphoserine aminotransferase 1 Psat1 0.6 0.5
AA800908 EST e 0.7 0.5
BE098713 EST e 0.5 0.5
AA964250 EST e 0.7 0.5
AW252428 EST e 0.7 0.5
BM384604 Similar to phosphoenolpyruvate
carboxykinase 2
e 0.7 0.5
BI282755 EST e 0.6 0.5
AI407489 Matrin F/G 1 Matr1 0.7 0.5
BM391851 EST e 0.6 0.5
BM386525 EST e 0.5 0.5
BI298526 EST e 0.2 0.6
BG671786 EST e 0.5 0.6
AW144216 Aminopeptidase A Enpep 0.5 0.7
EOA vs CO: early-stage OA vs control; LOA vs CO: late-stage OA vs control. List sorted according to the fold change of LOA vs CO in
ascending order.cartilage, whereas there was no signiﬁcant difference in
expression of AQP1 or AQP6 between OA and normal
controls. Over 70% of the total tissue weight in the cartilage
matrix consists of water and osteoarthritic cartilage in early-
stage OA is characterized by swelling with increased water
content1. Therefore water transport in the movement of
cartilage matrix and metabolic water across the membranes
of chondrocytes may be important in normal and patholog-
ical conditions of cartilage. The high expression of AQP3 in
OA cartilage suggests that it may play a particular role in
OA pathogenesis, but the mechanisms underlying this role
require further study.
Secreted phosphoprotein 2 (SPP2), a 24 kDa non-
collagenous protein, is a member of the cystatin superfam-
ily, which may modulate the thiol protease activities that are
known to be involved in bone turnover33. SPP2 has been
shown to be expressed in liver and bone, and also been
identiﬁed as a component of the fetuinemineral complex
and may play a role in inhibiting calciﬁcation34. SPP2 was
the most striking changed gene in the present study, being
up-regulated 19-fold in early-stage OA and 32-fold in late-
stage OA. Although the expression of cysteine proteinases
and their inhibitor, cystatin, in articular cartilage has been
studied extensively in OA, no direct correlation has been
reported between SPP2 and OA. Therefore, further study is
required to uncover its possible role in OA pathogenesis.The present work is the ﬁrst to link Dickkopf 3 (DKK3)
with OA progression. DKK3 is a member of the DKK family
which act as Wnt signaling regulators by inhibiting the Wnt
signaling pathway35. It has never been reported to be
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Fig. 5. Quantitative real-time RT-PCR analysis. Real-time RT-PCR
analysis of the selected differentially expressed genes from the
microarray results, and assays were performed in triplicate for each
gene. Data are presented as fold changes when comparing
osteoarthric cartilage vs normal cartilage. CO: normal control.
EOA: early-stage osteoarthritic cartilage. LOA: late-stage osteoar-
thritic cartilage. Values represent means with error bars. *P! 0.05.
1124 J. Meng et al.: Differential gene expression in TMJexpressed in cartilage. However, in the present study, there
was high expression of DKK3 in OA cartilage. Secreted
frizzled-related protein 4 (SFRP4), another inhibitor of the
Wnt signaling pathway, was also strongly up-regulated in
OA cartilage. SFRP4 inhibits Wnt action by competitively
binding to the Wnt ligand and was expressed in human
chondrocytes during severe OA14. Since the Wnt/frizzled
members inﬂuence cell proliferation, differentiation and
apoptosis36, the over-expression of DKK3 and SFRP4
suggests that Wnt signaling pathways may play a role in the
pathogenesis of OA.
NOV protein (NOV), a member of the CCN family,
participates in angiogenesis, chondrogenesis, and osteo-
genesis. All these processes are likely to be involved in the
control of cell proliferation and differentiation37. It has been
shown that NOV is expressed in the cartilage neoplasia and
hypertrophic chondrocytes of growth plates in embryonic
murine38. In the present study, strong up-regulation of NOV
was detected in OA cartilage, suggesting that NOV might
play a role in maintenance of speciﬁc cartilage functions or
repair of cartilage during OA progression. EGL nine
homolog 3 (EGLN3) has been implicated in the regulation
of growth, differentiation and apoptosis in muscle and nerve
cells39 and may promote caspase-dependent cell death.
Given the possibility that NOV and EGLN3 might be
involved in chondrocyte growth and apoptosis, further
research is needed to explore their possible roles in OA
pathogenesis.
In conclusion, the present study has provided a new and
comprehensive expression proﬁle of a large number of
genes during the progression of OA by using unbiased DNA
microarray quantitative analysis. Further investigation of the
precise functional roles of these genes during OA will
provide new insights in understanding the molecular
mechanisms of this disease and pave the way for new
therapeutic strategies and drug discovery.
Acknowledgments
We thank Ge Chen, Dengcheng Wu, Lu Sun for technical
assistance, Junming Wang and Xiaoming Ou for review.
This research was supported by the National Natural
Science Foundation of China (Grant Number: 30371543,
30171015).
References
1. Dijkgraaf LC, de Bont LG, Boering G, Liem RS. The
structure, biochemistry, and metabolism of osteoar-
thritic cartilage: a review of the literature. J Oral
Maxillofac Surg 1995;53:1182e92.
2. Okeson JP. Management of Temporomandibular Dis-
orders and Occlusion. 5th edn. St. Lousis: Mosby, Inc.
2003;151e8.
3. Dijkgraaf LC, de Bont LG, Boering G, Liem RS. Normal
cartilage structure, biochemistry, and metabolism:
a review of the literature. J Oral Maxillofac Surg
1995;53:924e9.
4. Gepstein A, Shapiro S, Arbel G, Lahat N, Livne E.
Expression of matrix metalloproteinases in articular
cartilage of temporomandibular and knee joints of
mice during growth, maturation, and aging. Arthritis
Rheum 2002;46:3240e50.5. Peat G, McCarney R, Croft P. Knee pain and
osteoarthritis in older adults: a review of community
burden and current use of primary health care. Ann
Rheum Dis 2001;60:91e7.
6. Felson DT, Zhang Y, Hannan MT, Naimark A, Weiss-
man BN, Aliabadi P. The incidence and natural
history of knee osteoarthritis in the elderly. The
Framingham Osteoarthritis Study. Arthritis Rheum
1995;38:1500e5.
7. Stewart CL, Standish SM. Osteoarthritis of the TMJ in
teenaged females: report of cases. J Am Dent Assoc
1983;106:638e40.
8. Livne. Matrix synthesis in mandibular condylar carti-
lage of aging mice. Osteoarthritis Cartilage 1994;2:
187e97.
9. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS,
Ray M, et al. Use of a cDNA microarray to analyse
gene expression patterns in human cancer. Nat Genet
1996;14:457e60.
10. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo
MV, Chee MS, et al. Expression monitoring by
hybridization to high-density oligonucleotide arrays.
Nat Biotechnol 1996;14:1675e80.
11. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasen-
beek M, Mesirov JP, et al. Molecular classiﬁcation of
cancer: class discovery and class prediction by gene
expression monitoring. Science 1999;286:531e7.
12. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L.
Anabolic and catabolic gene expression pattern
analysis in normal versus osteoarthritic cartilage using
complementary DNA-array technology. Arthritis
Rheum 2001;44:2777e89.
13. Connor JR, Kumar S, Sathe G, Mooney J, O’Brien SP,
Mui P, et al. Clusterin expression in adult human
normal and osteoarthritic articular cartilage. Osteoar-
thritis Cartilage 2001;9:727e37.
14. Zhang H, Liew CC, Marshall KW. Microarray analysis
reveals the involvement of beta-2 microglobulin (B2M)
in human osteoarthritis. Osteoarthritis Cartilage 2002;
10:950e60.
15. Stokes DG, Liu G, Coimbra IB, Piera-Velazquez S,
Crowl RM, Jimenez SA. Assessment of the gene
expression proﬁle of differentiated and dedifferentiated
human fetal chondrocytes by microarray analysis.
Arthritis Rheum 2002;46:404e19.
16. Vincenti MP, Brinckerhoff CE. Early response genes
induced in chondrocytes stimulated with the inﬂam-
matory cytokine interleukin-1beta. Arthritis Res 2001;
3:381e8.
17. Spears R, Oakes R, Moore C, Bellinger LL, Hutchins B.
A determination of tumor necrosis factor expression in
TMJ inﬂammation with the use of microarray analysis.
J Dent Res 2003;82:807e13.
18. Lekkas C, Honee GL, van den Hooff A. Effects of
experimental defects of the articular disc of the
temporomandibular joint in rats. J Oral Rehabil 1988;
15:141e8.
19. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H,
Cherry JM, et al. Gene ontology: tool for the uniﬁcation
of biology. The Gene Ontology Consortium. Nat
Genet 2000;25:25e9.
20. Nuovo GJ, Hohman RJ, Nardone GA, Nazarenko IA. In
situ ampliﬁcation using universal energy transfer-
labeled primers. J Histochem Cytochem 1999;47:
273e80.
21. Al-Shahrour F, Diaz-Uriarte R, Dopazo J. FatiGO:
a web tool for ﬁnding signiﬁcant associations of gene
1125Osteoarthritis and Cartilage Vol. 13, No. 12ontology terms with groups of genes. Bioinformatics
2004;20:578e80.
22. Toronen P, Kolehmainen M, Wong G, Castren E.
Analysis of gene expression data using self-organizing
maps. FEBS Lett 1999;451:142e6.
23. Lekkas C. Experimental degenerative temporomandib-
ular joint disease. Int J Oral Maxillofac Surg 1994;23:
423e4.
24. Aigner T, Bartnik E, Zien A, Zimmer R. Functional
genomics of osteoarthritis. Pharmacogenomics 2002;
3:635e50.
25. Coimbra IB, Jimenez SA, Hawkins DF, Piera-Velaz-
quez S, Stokes DG. Hypoxia inducible factor-1 alpha
expression in human normal and osteoarthritic chon-
drocytes. Osteoarthritis Cartilage 2004;12:336e45.
26. Komuro H, Olee T, Kuhn K, Quach J, Brinson DC,
Shikhman A, et al. The osteoprotegerin/receptor
activator of nuclear factor kappaB/receptor activator
of nuclear factor kappaB ligand system in cartilage.
Arthritis Rheum 2001;44:2768e76.
27. Shukunami C, Hiraki Y. Role of cartilage-derived anti-
angiogenic factor, chondromodulin-I, during endo-
chondral bone formation. Osteoarthritis Cartilage
2001;9(Suppl A):S91eS101.
28. Hayami T, Funaki H, Yaoeda K, Mitui K, Yamagiwa H,
Tokunaga K, et al. Expression of the cartilage derived
anti-angiogenic factor chondromodulin-I decreases
in the early stage of experimental osteoarthritis.
J Rheumatol 2003;30:2207e17.
29. Tabas JA, Zasloff M, Wasmuth JJ, Emanuel BS, Altherr
MR, McPherson JD, et al. Bonemorphogenetic protein:
chromosomal localization of human genes for BMP1,
BMP2A, and BMP3. Genomics 1991;9:283e9.
30. Martel-Pelletier J, Di Battista JA, Lajeunesse D, Pellet-
ier JP. IGF/IGFBP axis in cartilage and bone inosteoarthritis pathogenesis. Inﬂamm Res 1998;47:
90e100.
31. Trujillo E, Gonzalez T, Marin R, Martin-Vasallo P,
Marples D, Mobasheri A. Human articular chondro-
cytes, synoviocytes and synovial microvessels ex-
press aquaporin water channels; upregulation of
AQP1 in rheumatoid arthritis. Histol Histopathol
2004;19:435e44.
32. Mobasheri A, Trujillo E, Bell S, Carter SD, Clegg PD,
Martin-Vasallo P, et al. Aquaporin water channels
AQP1 and AQP3, are expressed in equine articular
chondrocytes. Vet J 2004;168:143e50.
33. Hu B, Coulson L, Moyer B, Price PA. Isolation and
molecular cloning of a novel bone phosphoprotein
related in sequence to the cystatin family of thiol
protease inhibitors. J Biol Chem 1995;270:431e6.
34. Price PA, Nguyen TM, Williamson MK. Biochemical
characterization of the serum fetuinemineral complex.
J Biol Chem 2003;278:22153e60.
35. Kawano Y, Kypta R. Secreted antagonists of the Wnt
signalling pathway. J Cell Sci 2003;116(Pt 13):
2627e34.
36. Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo
MW, et al. Wnt-1 signaling inhibits apoptosis by
activating beta-catenin/T cell factor-mediated tran-
scription. J Cell Biol 2001;152:87e96.
37. Perbal B. CCN proteins: multifunctional signaling
regulators. Lancet 2004;363:62e4.
38. Yu C, Le AT, Yeger H, Perbal B, Alman BA. NOV
(CCN3) regulation in the growth plate and CCN family
member expression in cartilage neoplasia. J Pathol
2003;201:609e15.
39. Taylor MS. Characterization and comparative
analysis of the EGLN gene family. Gene 2001;275:
125e32.
